CDC Endorses Covid-19 Test-to-Stay Strategy for K-12 Schools

Indonesia Berita Berita

CDC Endorses Covid-19 Test-to-Stay Strategy for K-12 Schools
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 WSJ
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

The CDC issued updated guidance that endorses frequent testing of K-12 students as a way to maintain in-person schooling even after exposure to a Covid-19 case

Schools can use frequent testing to keep students in class after exposure to someone with Covid-19, federal officials said, embracing a strategy some educators and parents have adopted to keep children out of home quarantines.

The Centers for Disease Control and Prevention on Friday updated its guidance for K-12 schools to include the strategy, known as . The CDC said testing students frequently after exposure to someone with Covid-19 can limit transmission of the virus while sustaining in-person learning.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

WSJ /  🏆 98. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsPfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Baca lebih lajut »

Covid-19: Nisra records increase in Covid-related deathsCovid-19: Nisra records increase in Covid-related deathsThe agency's Covid deaths total, based on mentions of the virus on death certificates, is 3,937.
Baca lebih lajut »

CDC recommends Pfizer, Moderna COVID-19 shots over J&J's | AP NewsCDC recommends Pfizer, Moderna COVID-19 shots over J&J's | AP NewsMost Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don't come with that risk and also appear more effective, said advisers to the Centers for Disease Control and Prevention.
Baca lebih lajut »

Eight heart inflammation cases among young kids who got COVID-19 shot - U.S. CDCEight heart inflammation cases among young kids who got COVID-19 shot - U.S. CDCThe U.S. Centers for Disease Control and Prevention said on Thursday it had received reports of eight cases of myocarditis, a type of heart inflammation, in children aged 5-11 years who received Pfizer and BioNTech's COVID-19 vaccine.
Baca lebih lajut »

CDC advisers recommend Pfizer, Moderna COVID-19 vaccines over J&J shot because of rare side effectCDC advisers recommend Pfizer, Moderna COVID-19 vaccines over J&J shot because of rare side effectMost Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health...
Baca lebih lajut »



Render Time: 2025-03-04 17:44:08